Riskpilot← Back to searchSign inGet full accessCALMEGO Psykiatri AB
ABActiveOrg 5591023840Svärdvägen 21Medical specialists activities · NACE 8622Est. 20171 employees
Revenue 2024
SEK 1,4M
-10% vs 2023
EBITDA margin
2.6%
-80% vs 2023
Equity ratio
61.7%
Financial strength
Net profit 2024
SEK 41K
-67% vs 2023
| Revenue | SEK 1,4M | -10% |
| EBITDA | SEK 38K | -80% |
| Net profit | SEK 41K | -67% |
| Total assets | SEK 611K | -22% |
| Equity | SEK 377K | -16% |
| Employees | 1 | — |
Legal name
CALMEGO Psykiatri AB
Org number
5591023840
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
28 februari 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom hälso- och sjukvård, läkartjänster, psykoterapi, därutöver äga och förvalta fast egendom, äga och förvalta fastigheter, förvalta och handla med värdepapper samt idka annan därmed förenlig verksamhet.
Address
Svärdvägen 21
Email
vmiloshevska@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 861 | 1 566 | 1 535 | 1 592 | 1 436 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 5 | 324 | 202 | 187 | 38 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 5 | 324 | 202 | 187 | 38 |
| Net financials | −241 | 67 | 31 | −46 | 13 |
| Profit before tax | −116 | 392 | 233 | 164 | 50 |
| Tax | −4 | −75 | −47 | −40 | −9 |
| Net profit | −120 | 317 | 186 | 124 | 41 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 313 | 621 | 673 | 780 | 611 |
| Equity | 61 | 378 | 444 | 448 | 377 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 152 | 143 | 129 | 233 | 134 |
| Total debt | 152 | 143 | 129 | 233 | 134 |
EBITDA margin
2.6%
This company
15.8%
Market median
-84% vs market
20202024
Equity ratio
61.7%
This company
38.2%
Market median
+62% vs market
20202024
Return on equity
10.9%
This company
18.4%
Market median
+41% vs market
20202024
Net profit margin
2.9%
This company
8.1%
Market median
-64% vs market
20202024
Asset turnover
2.35×
This company
1.12×
Market median
+110% vs market
20202024
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
VM Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
FG | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CALMEGO Psykiatri AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Viktorija Milosevska Aleksikj | Chief Executive Officer | 0 companies |
| Fredrik Gunnar Petersson | Audit | 0 companies |
| Boban Aleksikj | Deputy Board Member | 0 companies |